Cancer of the Prostate: Epidemiology and Aetiology
1987; Wiley; Volume: 59; Issue: 6 Linguagem: Inglês
10.1111/j.1464-410x.1987.tb04862.x
ISSN1365-2176
Autores Tópico(s)Lymphoma Diagnosis and Treatment
ResumoBritish Journal of UrologyVolume 59, Issue 6 p. 493-502 Cancer of the Prostate: Epidemiology and Aetiology D.G. ZARIDZE, D.G. ZARIDZE All-Union Cancer Research Centre, Academy of Medical Sciences of the USSR, Moscow, USSRSearch for more papers by this authorP. BOYLE, P. BOYLE Division of Epidemiology and Biostatistics, International Agency for Research on Cancer, Lyon, FranceSearch for more papers by this author D.G. ZARIDZE, D.G. ZARIDZE All-Union Cancer Research Centre, Academy of Medical Sciences of the USSR, Moscow, USSRSearch for more papers by this authorP. BOYLE, P. BOYLE Division of Epidemiology and Biostatistics, International Agency for Research on Cancer, Lyon, FranceSearch for more papers by this author First published: June 1987 https://doi.org/10.1111/j.1464-410X.1987.tb04862.xCitations: 75AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References Ablin, R. J. (1976). Serum antibody in patients with prostatic cancer. Br. J. Urol., 48, 355–361. Andjelkovic, D., Taulbee, J., Symons, M. and Williams, T. (1977). Mortality of rubber workers with reference to work experience. J. Occup. Med., 19, 397–405. Armenian, H. K., Lilienfeld, A. M., Diamond, E. L. and Bross, I. D. (1974). Relation between benign prostatic hyperplasia and cancer of the prostate: a prospective and retrospective study. Lancet, II, 115–117. Armenian, H. K., Lilienfeld, A. M., Diamond, E. L. and Bross, I. D. J. (1975). Epidemiologic characteristics of patients with prostate neoplasms. Am. J. Epidemiol., 102, 47–54. Armstrong, B. and Doll, R. (1975). Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int. J. Cancer, 15, 617–631. Baker, H. W. G., Burger, H. C. and De Kretser, D. M. (1976) Changes in the pituitary-testicular system with age. Clin. Endocrinol., 5, 349–372. Bartsch, W., Steins, P. and Becker, H. (1977). Hormone blood levels in patients with prostatic carcinoma and their relation to the type of carcinoma growth differentiation. Eur. Urol., 7, 129–135. Berg, J. W. (1975). Can nutrition explain the pattern of international epidemiology of hormone-dependent cancers? Cancer Res., 35, 3345–3350. Blair, A. and Fraumeni, J. F. (1978). Geographic patterns of prostate cancer in the United States. J. Natl. Cancer Inst., 61, 1379–1384. Breslow, N., Chan, C. E., Dhom, G., Drury, R. A. B., Franks, L. M., Gellei, B., Lee, Y. S., Lundberg, S., Sparke, B., Sternby, N. H. and Tulinius, H. (1977). Latent carcinoma of prostate at autopsy in seven areas. Int. J. Cancer, 20, 680–688. Burbank, F. A. (1972). Sequential space-time cluster analysis of cancer mortality in the United States: etiologic implications. Am. J. Epidemiol., 95, 393–417. Centifanto, Y. M., Zam, Z. S., Kaufman, H. E. and Drylie, D. M. (1975). In vitro transformation of hamster cells by herpes simplex virus type 2 from human prostatic cancer cells. Cancer Res., 35, 1880–1886. Chopra, D. P. and Wilkoflf, L. J. (1981). Effects of carcinogens and retinoids on prostatic explants. Clin. Androl., 6, 166–174. Cook, P. J., Doll, R. and Fellingham, S. A. (1969). A mathematical model for the age distribution of cancer in man. Int. J. Cancer, 4, 93–112. Dhar, N. K., Goel, T. C., Dube, P. C., Chowdhury, A. R. and Kar, A. B. (1973). Distribution and concentration of zinc in the subcellular fractions of benign hyperplastic and malignant neoplastic human prostate. Exp. Mol. Pathol., 19, 139–142. Farnsworth, W. E., Slaunwhite, W. R., Sharma, M., Oseka, F., Brown, J. R., Gonder, M. J. and Cartagena, R. (1981) Interaction of prolactin and testosterone in the human prostate. Urol. Res., 9, 79–88. Feminella, J.G. and Lattimer, J. K. (1973). An apparent increase in genital carcinomas among wives of men with prostatic cancer. Pirquet Bull. Clin. Med., 20, 3–10. Franks, L. M. (1954). Latent carcinoma of the prostate. J. Pathol. Bacteriol., 68, 603–616. Franks, L. M. (1972). The incidence of carcinoma of prostate: an epidemiological survey. Recent Results Cancer Res., 39, 149–155. Geder, L., Sanford, E. J., Rohner, T. J. and Rapp, F. (1977) Cytomegalovirus and cancer of the prostate: in vitro transformation of human cells. Cancer Treat. Rep., 61, 139–146. Geller, J., Albert, J., de la Vega, D., Loza, D. and Stoeltzing, W. (1978). Dihydrotestosterone concentration in prostate cancer tissue as a predictor of tumor differentiation and hormonal dependency. Cancer Res., 38, 4349–4352. Ghanadian, R., Puah, C. M. and O'Donoghue, E. P. N. (1979) Serum testosterone and dihydrotestosterone in carcinoma of the prostate. Br. J. Cancer, 39, 696–699. Goldsmith, D. F., Smith, A. H. and McMichael, A. J. (1980) A case-control study of prostate cancer within a cohort of rubber and tyre workers. J. Occup. Med., 22, 533–541. Graham, S., Haughey, B., Marshall, J., Priore, R., Byers, T., Rzepka, T., Mettling, C. and Pontes, J. E. (1983). Diet in the epidemiology of carcinoma of the prostate gland. J. Natl. Cancer Inst., 70, 687–692. Greenwald, P., Damon, A., Kirmss, V. and Polan, A. K. (1974). Physical and demographic features of men before developing cancer of the prostate. J. Natl. Cancer Inst., 53, 341–346. Greenwald, P., Kirmss, V. and Burnett, W. S. (1979). Prostate cancer epidemiology. Widowhood and cancer in spouses. J. Natl. Cancer Inst., 62, 1131–1136. Griffiths, K., Peeling, W. B., Groom, G. U., Sibley, P. E. and Harper, M. E. (1980). Protein hormones and prostatic cancer. Prog. Cancer Res. Ther., 144, 185–192. Guileyardo, J. M., Johnson, W. D., Welsh, R. A., Akazaki, K. and Correa, P. (1980). Prevalence of latent prostate carcinoma in two U.S. populations. J. Natl. Cancer Inst., 65, 311–316. Gunn, S. A., Gould, T. C. and Anderson, W. A. D. (1961). Competition of cadmium for zinc in rat testis and dorsolateral prostate. Acta Endocrinol., 37, 24–30. Gyorkey, F., Min, K. W., Huff, J. A. and Gyorkey, P. (1967) Zinc and magnesium in human prostate—normal, hypertrophic and neoplastic. Cancer Res., 27, 1348–1353. Habib, F. K., Lee, I. R., Stitch, S. R. and Smith, P. H. (1976) Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate. J. Endocrinol., 71, 99–107. Haenszel, W. and Kurihara, M. (1968). Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J. Natl. Cancer Inst., 40, 43–68. Hammond, G. L. (1978). Endogenous steroid levels in the human prostate from birth to old age: a comparison of normal and diseased tissues. J. Endocrinol., 78, 7–19. Hammond, G. L., Kontturi, M., Määttälä, P., Puukka, M. and Vhiko, R. (1977). Serum FSH, LH and prolactin in normal males and patients with prostatic diseases. Clin. Endocrinol., 7, 129–135. Harper, M. E., Peeling, W. B., Cowley, T., Brownsey, B. G., Phillips, M. E. A., Groom, G., Fahmy, D. R. and Griffiths, K. (1976). Plasma steroid and protein hormone concentrations in patients with prostatic carcinoma, before and during oestrogen therapy. Acta Endocrinol., 81, 409–426. Heston, J. F., Kelly, J. A. B., Meigs, J. W. and Flannery, J. T. (1986). Forty-five Years of Cancer Incidence in Connecticut: 1935–1979. NCI Monograph 70. Bethesda : National Cancer Institute. Hill, P., Wynder, E. L., Garbaczewski, L., Games, H. and Walker, A. R. P. (1979). Diet and urinary steroids in black and white North American men and black South African men. Cancer Res., 39, 5101–5105. Hill, P., Wynder, E. L., Games, H. and Walker, A. R. P. (1980) Environmental factors, hormone status and prostatic cancer. Prev. Med., 9, 657–666. Hirayama, T. (1979). Epidemiology of prostate cancer with special reference to the role of diet. Natl. Cancer Inst. Monogr., 53, 149–155. Howell, M. A. (1974). Factor analysis of international cancer mortality data and per capita food consumption. Br. J. Cancer, 29, 328–336. International Agency for Research on Cancer (1973). Some Inorganic and Organometallic Compounds. IARC Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Volume 2. Lyon : International Agency for Research on Cancer. Jackson, M. A., Kovi, J., Heshmat, M. Y., Jones, G. W., Rao, M. S. and Ahlwalia, B. S. (1980). Characterization of prostatic carcinoma among blacks: a comparison between a low-incidence area, Ibadan, Nigeria, and a high-incidence area, Washington, DC. Prostate, 1, 185–205. Jacobi, G. H., Rathgen, G. H. and Altwein, J. E. (1980) Serum prolactin and tumors of the prostate: unchanged basal levels and lack of correlation to serum testosterone. J. Endocrinol. Invest., 3, 15–18. King, M., Diamond, E. and Lilienfeld, A. M. (1963) Some epidemiological aspects of cancer of the prostate. J. Chronic Dis., 16, 117–153. King, H. and Haenszel, W. (1968). Cancer mortality among foreign- and native-born Chinese in the United States. J. Chronic Dis., 26, 623–646. Kipling, M. D. and Waterhouse, J. A. H. (1967) Cadmium and prostatic carcinoma. Lancet, I, 730–731. Kolonel, L. N., Hankin, J. H., Lee, J., Chu, S. Y., Nomura, A. M. Y. and Hinds, M. W. (1981). Nutrient intakes in relation to cancer incidence in Hawaii. Br. J. Cancer, 44, 332–339. Kolonel, L. N. and Winkelstein, W. (1977). Cadmium and prostatic carcinoma. Lancet, II, 566–567. Krain, L. S. (1974). Some epidemiologic variables in prostatic carcinoma in California. Prev. Med., 3, 154–159. Krieg, M., Bartsch, W. and Voigt, K. D. (1980). Binding, metabolism and tissue level of androgens in human prostatic carcinoma, benign prostatic hyperplasia and normal prostate. Exerpta Med. I.C.S., 494, 102–104. Lancaster, H. O. (1972). The mortality in Australia from cancer peculiar to the male. Med. J. Aust., 2, 41–44. Levy, L. S. and Clack, J. (1975). Further studies on the effect of cadmium on the prostate gland. I. Absence of prostatic changes in rats given oral cadmium sulphate for two years. Ann. Occup. Hyg., 17, 205–211. Levy, L. S., Clack, J. and Roe, F. J. C. (1975). Further studies on the effect of cadmium on the prostate gland. II. Absence of prostatic changes in mice given oral cadmium sulphate for eighteen months. Ann. Occup. Hyg., 17, 213–220. Lilienfeld, A. M., Levin, M. L. and Kessler, I.I. (1972). Cancer in the United States. American Public Health Association Monograph. Cambridge : Harvard University Press. Lyon, J. L., Gardner, J. W. and West, D. W. (1980). Cancer risk and life-style: cancer among Mormons from 1967–1975. In Cancer Incidence in Defined Populations, ed. J. Cairns, J. L. Lyon and M. Skolnick Banbury Report 4, pp. 3–30. New York : Cold Spring Harbor Laboratory. McMichael, A. J., Spirtas, R., Gamble, J. F. and Tousey, P. M. (1976). Mortality among rubber workers: Relationship to specific jobs. J. Occup. Med., 18, 178–185. Noble, K. L. (1977). The development of prostate adenocarcinoma in the Nb rat following prolonged sex hormone administration. Cancer Res., 37, 1929–1933. Parkin, D. M., Stjernswärd, J. and Muir, C. S. (1984). Estimates of the worldwide frequency of twelve major cancers. Bull. W. H. O., 62, 163–182. Paulson, D. F., Bonar, R. A., Sharief, Y., Vergara, J. R., Reich, C. and Shah, K. V. (1975). Properties of prostatic cultures transformed by SV-40. Cancer Chemother. Rep., 59, 51–55. Phillips, R. L., Kuzma, J. W. and Lotz, T. M. (1980). Cancer mortality among comparable members versus non-members of the Seventh-Day Adventist Church. In Cancer Incidence in Defined Populations, ed. J. Cairns, J. L. Lyon and M. Skolnick Banbury Report 4, pp. 93–108. New York : Cold Spring Harbor Laboratory. Pirke, K. M. and Doer, P. (1975). Age-related changes in free plasma testosterone, dihydrotestosterone and oestradiol. Acta Endocrinol., 80, 171–178. Rolandi, E., Pescatore, D., Milesi, G. M., Giberti, C., Sannia, A. and Barreca, T. (1980). Evaluation of LH, FSH, TSH, Prl and GH secretion in patients suffering from prostatic neoplasma. Acta Endocrinol., 95, 23–26. Rotkin, I. D. (1977). Studies on the epidemiology of prostatic cancer: Expanded sampling. Cancer Treat. Rep., 61, 173–180. Saroff, J., Kirdani, Y., Ming Chu T., Wajsman, Z. and Murphy, G. P. (1980). Measurements of prolactin and androgens in patients with prostatic diseases. Oncology, 37, 46–52. Schrauzer, G. N., White, D. A. and Schneider, C. J. (1977). Cancer mortality correlation studies—III. Statistical associations with dietary selenium intakes. Bioinorgan. Chem., 7, 23–34. Schrodt, G. R., Hall, T. and Whitmore, W. R. (1964). The concentration of zinc in diseased human prostate gland. Cancer, 17, 1555–1556. Schuman, L. M., Mandel, J., Blackard, C., Bauer, H., Scarlett, J. and McHugh, R. (1977). Epidemiologic study of prostatic cancer: preliminary report. Cancer Treat. Rep., 61, 181–186. Steele, R., Lees, R. E. M., Kraus, A. S. and Rao, C. (1971). Sexual factors in the epidemiology of cancer of the prostate. J. Chronic Dis., 24, 29–37. Vermeulen, A., Rubens, R. and Verdonck, L. (1972). Testosterone secretion and metabolism in male senescence. J. Clin. Endocrinol. Metab., 34, 730–735. J. A. H. Waterhouse, C. S. Muir, P. Correa and J. Powell, (eds) (1978). Cancer Incidence in Five Continents. Volume 3. IARC Scientific Publication No. 15. Lyon : International Agency for Research on Cancer. J. A. H. Waterhouse, C. S. Muir, K. Shanmugaratnam and J. Powell, (eds) (1982). Cancer Incidence in Five Continents, Volume IV. IARC Scientific Publication No. 42. Lyon : International Agency for Research on Cancer. Webber, M. M., Stonington, O. G. and Lehman, J. (1973). Virus in prostatic epithelium of man. Urology, 1, 561–567. Wynder, E. L., Laakso, K., Sotaranta, M. and Rose D. P. (1984). Metabolic epidemiology of prostatic cancer. Prostate, 5, 47–53. Wynder, E. L., Mabuchi, K. and Whitmore, W. F. (1971). Epidemiology of cancer of the prostate. Cancer, 28, 344–360. Yatani, R., Chigusa, K., Akazaki, K., Stemmermann, G. N., Welsh, R. A. and Correa, P. (1982). Geographic pathology of latent prostatic carcinoma. Int. J. Cancer, 29, 611–616. Zaridze, D. G., Boyle, P. and Smans, M. (1984). Trends in prostatic cancer. Int. J. Cancer, 33, 223–230. Citing Literature Volume59, Issue6June 1987Pages 493-502 ReferencesRelatedInformation
Referência(s)